Details

Autor(en) / Beteiligte

• Lu, Yu
• Feng, Ye
• Yi-Yi, Li
• Yi-Zhi, Zhan
• Yang, Liu
• Hong-Mei, Yan
• Yuan, Fang
• Yu-Wen, Xie
• Feng-Jiao, Zhang
• Long-Hua, Chen
• Yi, Ding
• Ke-Li, Chen

Titel

Histone Methyltransferase SETDB1 Promotes Colorectal Cancer Proliferation through the STAT1-CCND1/CDK6 Axis

Ist Teil von

• Carcinogenesis (New York), 2020-07, Vol.41 (5), p.678-688

Ort / Verlag

England

Erscheinungsjahr

2020

Link zum Volltext

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• Upregulation of histone methyltransferase SETDB1 is associated with poor prognosis in cancer patients. However, the mechanism of oncogenicity of SETDB1 in cancer is hitherto unknown. Here, we show that SETDB1 is upregulated in human colorectal cancer (CRC) where its level correlates with poor clinical outcome. Ectopic SETDB1 promotes CRC cell proliferation, whereas SETDB1 attenuation inhibits this process. Flow cytometry reveals that SETDB1 promotes proliferation by driving the CRC cell cycle from G0/G1 phase to S phase. Mechanistically, SETDB1 binds directly to the STAT1 promoter region resulting in increased STAT1 expression. Functional characterization reveals that STAT1-CCND1/CDK6 axis is a downstream effector of SETDB1-mediated CRC cell proliferation. Furthermore, SETDB1 upregulation is sufficient to accelerate in vivo proliferation in xenograft animal model. Taken together, our results provide insight into the upregulation of SETDB1 within CRC and can lead to novel treatment strategies targeting this cell proliferation-promoting gene.